Status:
COMPLETED
Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)
Lead Sponsor:
Merck Sharp & Dohme LLC
Collaborating Sponsors:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Mycoses
Leukemia
Eligibility:
All Genders
Brief Summary
This will be a retrospective study that includes retrospective chart reviews at major institutions across Canada. The intent of the study is to generate both regional and national incidence data for n...
Eligibility Criteria
Inclusion
- To be eligible for study inclusion, the participant must have:
- A hematological malignancy requiring high dose chemotherapy with or without bone marrow transplant
Exclusion
- The participant is not eligible for study inclusion if:
- Their IFI is not related to hematological malignancies.
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT01254318
Start Date
March 1 2013
End Date
November 1 2014
Last Update
November 2 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.